SG54341A1 - Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines - Google Patents

Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines

Info

Publication number
SG54341A1
SG54341A1 SG1996009983A SG1996009983A SG54341A1 SG 54341 A1 SG54341 A1 SG 54341A1 SG 1996009983 A SG1996009983 A SG 1996009983A SG 1996009983 A SG1996009983 A SG 1996009983A SG 54341 A1 SG54341 A1 SG 54341A1
Authority
SG
Singapore
Prior art keywords
pyrazola
triazolo
pyridines
tricyclic
dihydro
Prior art date
Application number
SG1996009983A
Other languages
English (en)
Inventor
Allen Jacob Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG54341A1 publication Critical patent/SG54341A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1996009983A 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines SG54341A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SG54341A1 true SG54341A1 (en) 1998-11-16

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009983A SG54341A1 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazola[3,4-c] 1,2,4-triazolo[4,3-alpha] pyridines

Country Status (43)

Country Link
US (1) US6004974A (de)
EP (1) EP0837860B1 (de)
JP (1) JP3107827B2 (de)
KR (2) KR100191972B1 (de)
CN (1) CN1061044C (de)
AP (1) AP609A (de)
AR (1) AR002745A1 (de)
AT (1) ATE214700T1 (de)
AU (1) AU694871B2 (de)
BG (1) BG62568B1 (de)
BR (1) BR9602627A (de)
CA (1) CA2223624C (de)
CO (1) CO4700460A1 (de)
CZ (1) CZ287251B6 (de)
DE (1) DE69525978T2 (de)
DK (1) DK0837860T3 (de)
DZ (1) DZ2044A1 (de)
ES (1) ES2172583T3 (de)
FI (1) FI114097B (de)
HR (1) HRP960268B1 (de)
HU (1) HUP9601541A3 (de)
IL (1) IL118485A (de)
IS (1) IS1913B (de)
LV (1) LV11620B (de)
MA (1) MA23893A1 (de)
MX (1) MX9709897A (de)
MY (1) MY116527A (de)
NO (1) NO306256B1 (de)
NZ (1) NZ286734A (de)
OA (1) OA10458A (de)
PL (1) PL184195B1 (de)
PT (1) PT837860E (de)
RO (1) RO115881B1 (de)
RU (1) RU2161158C2 (de)
SA (1) SA96170065B1 (de)
SG (1) SG54341A1 (de)
SI (1) SI9600186A (de)
SK (1) SK282167B6 (de)
TN (1) TNSN96083A1 (de)
TR (1) TR199600482A1 (de)
TW (1) TW460469B (de)
WO (1) WO1996039408A1 (de)
YU (1) YU49346B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
US6326495B2 (en) * 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1380585B1 (de) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinon als Zwischenprodukt
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
WO2001068600A2 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Limited Benzylated pde4 inhibitors
ES2276942T3 (es) * 2001-05-25 2007-07-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Combinacion de un inhibidor de pde4 y tiotropio o un derivado del mismo para tratar vias respiratorias obstructivas y otras enfermedades inflamatorias.
CA2446613A1 (en) * 2001-05-25 2002-12-05 Pfizer Inc. A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
AU2006258124B8 (en) * 2005-06-10 2010-01-07 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
ES2378281T3 (es) 2006-07-05 2012-04-10 Nycomed Gmbh Combinación de atorvastatina con un inhibidor de fosfodiesterasa 4 para el tratamiento de neumopatías inflamatorias
WO2010043676A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
US9127015B2 (en) 2009-12-04 2015-09-08 Nerviano Medical Sciences S.R.L. Tricyclopyrazole derivatives
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
SU1048746A1 (ru) * 1982-01-29 1987-12-30 Институт физико-органической химии и углехимии АН УССР Гидробромид 8-адамантил-1,з-диметилимидазо 4,5-с имидазо 1,2-а пиридин-2-она,обладающий спазмолитическим действием
FR2579208B1 (fr) * 1985-03-22 1987-05-07 Sanofi Sa Nouveaux derives de le 5-h pyrido (3', 4' : 4,5) pyrrolo (3,2-c) pyridine, leur procede de preparation et leur activite antitumorale
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
AU695301B2 (en) * 1993-07-06 1998-08-13 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
EP0837860A1 (de) 1998-04-29
IL118485A0 (en) 1996-09-12
YU34696A (sh) 1999-07-28
CA2223624A1 (en) 1996-12-12
LV11620B (en) 1997-04-20
ATE214700T1 (de) 2002-04-15
FI974434L (fi) 1997-12-05
DZ2044A1 (fr) 2002-07-21
BG100640A (bg) 1997-03-31
NO962320D0 (no) 1996-06-05
BR9602627A (pt) 1998-09-01
CZ287251B6 (en) 2000-10-11
WO1996039408A1 (en) 1996-12-12
CO4700460A1 (es) 1998-12-29
ES2172583T3 (es) 2002-10-01
NO962320L (no) 1996-12-09
AU5477396A (en) 1996-12-19
HRP960268B1 (en) 2002-12-31
NZ286734A (en) 1998-02-26
DE69525978T2 (de) 2002-12-19
AP609A (en) 1997-09-03
BG62568B1 (bg) 2000-02-29
MA23893A1 (fr) 1996-12-31
RO115881B1 (ro) 2000-07-28
SK71896A3 (en) 1997-05-07
AR002745A1 (es) 1998-04-29
HU9601541D0 (en) 1996-07-29
HRP960268A2 (en) 1997-08-31
CA2223624C (en) 2001-02-20
NO306256B1 (no) 1999-10-11
KR100191972B1 (ko) 1999-06-15
PL314459A1 (en) 1996-12-09
CN1142499A (zh) 1997-02-12
IS1913B (is) 2004-02-03
AU694871B2 (en) 1998-07-30
FI114097B (fi) 2004-08-13
FI974434A0 (fi) 1997-12-05
CZ162696A3 (en) 1997-01-15
US6004974A (en) 1999-12-21
OA10458A (en) 2002-03-27
TR199600482A1 (tr) 1997-03-21
HUP9601541A2 (en) 1997-02-28
KR100225719B1 (en) 1999-10-15
IL118485A (en) 2000-02-17
TNSN96083A1 (fr) 2005-03-15
SI9600186A (en) 1997-04-30
JPH10510242A (ja) 1998-10-06
EP0837860B1 (de) 2002-03-20
LV11620A (lv) 1996-12-20
TW460469B (en) 2001-10-21
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
SK282167B6 (sk) 2001-11-06
KR970003440A (ko) 1997-01-28
YU49346B (sh) 2005-07-19
PL184195B1 (pl) 2002-09-30
DE69525978D1 (de) 2002-04-25
JP3107827B2 (ja) 2000-11-13
IS4350A (is) 1996-12-07
RU2161158C2 (ru) 2000-12-27
AP9600806A0 (en) 1996-07-31
MY116527A (en) 2004-02-28
CN1061044C (zh) 2001-01-24
HUP9601541A3 (en) 1997-05-28
MX9709897A (es) 1998-03-31
DK0837860T3 (da) 2002-05-27

Similar Documents

Publication Publication Date Title
IL113912A0 (en) Thieno [1,5] benzodiazepine use
PL322623A1 (en) Derivatives of imidazo [1,2-a] pyridine
NZ306035A (en) 6-substituted pyrazolo[3,4-d]pyrimidine-4-ones and their use
DE59409351D1 (de) Pyrrolo[3,4-c]pyrrole
ZA942571B (en) 1,5 benzodiazepine derivatives
AU4025789A (en) Tricyclic benzodiazepine derivatives
HRP960268B1 (en) TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES
AP9400657A0 (en) 1,5 benzodiazepine derivatives
IL124453A0 (en) 2,7-substituted octahydro-pyrrolo [1,2-A]pyrazine derivatives
AU698867B2 (en) Fused imidazo 1,2-a pyridines
ZA892968B (en) 6-aryl-substituted-4h-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)-diazepines
HU9901909D0 (en) Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrroles]
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
GB9616467D0 (en) Pyrrolo[3,2-c]quinoline derivatives
GB9317692D0 (en) Benzodiazepine derivatives
GB9320113D0 (en) Tricyclic derivatives
HU9500007D0 (en) Tricyclic cepheme derivatives
ZA964649B (en) Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
ZA94382B (en) Tricyclic 1,2,4-triazolo compounds
HU0200040D0 (en) Thiazolo[3,2-a]azepine derivatives and process for their preparation
GB9518219D0 (en) Pyrrolo[3,2-C]Quinoline Derivatives
IL135582A0 (en) PYRROLO[3,2-b]PYRIDINE PROCESSES AND INTERMEDIATES
HUP9902614A3 (en) Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use
GB9308013D0 (en) Benzodiazepine derivatives
GB9322270D0 (en) Benzodiazepine derivatives